A*STAR’s Genome Institute of Singapore (GIS) fellow, Dr Wan Yue, has become the first Singaporean to receive the prestigious Branco Weiss Fellowship given by the Swiss-based ‘Society in Science’ philanthropic organisation.
The fellowship program was initiated and financed by the Swiss entrepreneur Dr. Branco Weiss, who passed away in October 2010. The organisation gives out 10 fellowships to outstanding scientists every year and come with a grant to further each scientist’s research.
In recognition of Dr Wan’s work, ‘Society in Science’ has awarded S$700,000 towards her research to tackle the global health issue of Antimicrobial Resistance (AMR).
According to a 2014 World Health Organization report, AMR threatens the effective prevention and treatment of an increasing range of infections caused by bacteria, parasites, viruses and fungi[1]. This is because common bacteria are becoming resistant to treatments in many parts of the world. WHO says that there is an urgent need to develop new ways to deal with the rise in AMR.
A key step to tackling AMR is to find out how pathogenic microorganisms attain their ability to resist the effects of antimicrobial drugs. Dr Wan aims to shed light on microbial drug resistance by studying the genes or RNA of microbes. It is hoped that her research will uncover critical genetic junctures in microbes that will come in useful in the search for new antimicrobial treatments.
Dr Wan was one of the first scientists to develop a high throughput approach to study RNA shapes in microorganisms. An aspect of the study is to look at how pathogenic microorganisms sense and respond to their environment for survival and pathogenesis, such as Listeria monocytogenes bacteria that utilises an RNA switch that encodes virulent proteins that harm the body. At room temperature, the bacteria’s RNA is inactive, but when exposed to higher temperatures, like in the body, the RNA switch is “turned on” and activates the bacteria’s production of virulent proteins. Many such RNA switches remain to be discovered in clinically important pathogens. By understanding the biological pathway that switches microbial RNA on and off, Dr Wan plans to identify elements within the pathway that can be targeted by future drugs.
wan yue“I am extremely honoured to receive the Branco Weiss Fellowship for Society in Science,” said Dr Wan. “The ultimate goal of scientific discoveries is to advance human society. I am excited that my technology can contribute innovative solutions to existing problems, such as anti-microbial resistance, in our society. I hope that this investment in science will help shape our future.”
Prof Ng Huck Hui, Executive Director of GIS, said, “GIS is exceedingly proud of Dr Wan’s achievements. It means a lot that our young scientists such as Dr Wan are able to compete internationally for an award that is given to high-potential researchers, with a passion to advance the society through blazing new trails in impactful research. Dr Wan’s research in identifying unknown RNA switches in pathogens has the potential to transform the way to fight pathogens in human diseases.”
“For decades, antibiotics have been one of the pillars that allowed us to live longer and healthier. But the emergence of antimicrobial resistance threatens to pull us back from medical advances humans have made,” said Dr Benjamin Seet, Executive Director of the Biomedical Research Council, A*STAR. “Dr Wan Yue is a good example of the brilliant talents that are contributing to A*STAR’s goal of creating excellent science towards better healthcare in society.”
Dr Wan graduated with a BSc in Biochemistry and Cell Biology from the University of California, San Diego, and received her PhD in Cancer Biology from Stanford University, USA. She was also a recipient of the A*STAR National Science Scholarship in 2003.

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments
You May Also Like

National Youth Council partners Redd+E to engage youth purposefully through esports

Earlier this week, the National Youth Council (NYC) forged a partnership with…

陆交局:个人代步工具频传意外,探讨提前禁止期限

个人代步工具近日来频频传出意外,陆交局正在探讨是否应提前将禁止不符合规格的个人代步工具(PMD)。 尽管自本月起,禁止出售无UL2272规格的个人代步工具,但目前拥有未符合该规格的个人代步工具,至2020年12月31日仍可在路上使用。 当局日前宣布,从2021年1月起,在公共路径使用不符合UL2272标准的电动个人代步工具,将是违例的。陆交局是在征询公众和业者的意见后,才定下这个期限。 个人代步工具一直以来都是我国争议话题,此前,已传出许多因个人代步工具的交通意外或火灾,如日前宏茂桥与武吉巴督的火灾,疑似因个人代步工具引起火患,导致周遭房子损毁,甚至一人伤重不治。 陆交局向《海峡时报》透露,“由于近期发生的火灾意外均与未符合UL2272规格的个人代步工具有关,故陆交局正在探讨是否将期限提前。” UL2272第一版在数年前正式发布后,很快就升级为美国和加拿大两国国家标准。该标准规范对象不仅涵盖电动平衡车,更扩大至电动滑板车、电动滑板鞋等各种个人电动代步载具,要求范畴包括零部件、电性能、机械性能、环境测试、电机测试和避免过度充电等等一系列安全。 去年发生74起和个人代步工具有关火患 近期,因个人代步工具而引起火患事件逐渐提升,根据陸交局数据显示,2018年已有74个人代步工具相关引起的火患,比起2017年,增长了51巴仙。因此,陆交局表示为公共安全与减少火患,自2018年9月已采用相关标准规定个人代步工具。经询问调查公共意见后,最终决定于2020年12月正式实施。 “我们强烈建议购买个人代步工具时,应从可靠来源购买,并检查他们UL2272的认证。民众亦应避免过长充电、更换内部电池与组件。”陆交局表示。 国大教授Raymond Ong亦披露,基于安全理由,设下期限是必要的,然而应予以驾驶者足够的事件更换合格的零件。 “UL2272规格内包含各项工具与零件的更换,可减低引发火患的可能性。最重要的是,我们需要提供消费者安全与可靠的认证。”…

Why no historian on Founders’ Memorial committee?

Historically important monument but no historians on committee The composition of the…

陆交局逾两亿元建地铁站合约 颁中铁建十一局

根据陆路交通管理局(LTA)昨日(9日)发布的文告,当局把裕廊西和峇哈路口(Bahar Junction)(皆暂定名称)两个地铁站,以及裕廊区域线(JRL)高架桥的土木工程合约,颁给中国铁建十一局集团新加坡分公司。合约总值2亿1千010万元。 合约要求设计和建设裕廊西和峇哈路口地铁站,以及裕廊西2道与4道、以及裕廊西64街和75街的高架桥;而峇哈路口地铁站则有两个平台,其中一平台服务列车开往蔡厝港和裕廊渡头;另一平台开往秉光山方向。 根据陆交局的文告简介,中铁建十一局是“经验丰富的建筑公司,在全球已完成多项铁路项目。” 在新加坡,该公司参与多项重大建筑项目,包大士西延长线上的三个地铁站,即大士连路站、大士西路站及大士弯站与其高架轨道。“在大士西延长线项目中,建造了我国首个与部分地铁轨道结合兴建的汽车高架桥。” 据此前报导,陆交局也颁发总值7亿3950万元的土木工程合约,给中铁建十一局新加坡分公司,负责建设登加(Tengah)车厂。 裕廊区域线是新加坡第七条地铁线路,总长24公里共24站。上述车站将在2020年动工,预计2026年竣工。裕廊区域线预计从2026年起至2028年分三个阶段启用。 根据中铁建十一局集团官网简介,指该公司是中国铁建有限公司(CRCC)的“骨干子公司”;前身为中国人民解放军铁道第一师,诞生于1948年;1984年改编为铁道部第十一工程局、以及2001年8月改制为中铁十一局集团有限公司,2008年3月随中国铁建整体上市。 不过有消息指,世界银行在今年6月,对该公司以及中国铁建,发布为期九个月的禁令,主要原因是涉及格鲁吉亚东西公路走廊改善项目中,采购过程存不当行为 。 禁令将在明年3月3日结束,此后两年将施以“附条件解禁”,世界银行将监督该公司以及中国铁建的其他涉事公司,确保履行和解协议的义务。 与此同时,该公司还曾在去年8月至11月期间,被人力部列入黑名单: